Daily Symptom Fluctuations and Functional Impact in Fibromyalgia
Key facts
- Where
- Mardin, TürkiyeSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07826520, who can take part
Where in Türkiye
- Mardin Training and Research HospitalMardin, TürkiyeContact: Taha Yasin Yıldırım, M.D.Taking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Mardin Artuklu University
- Trial code
- NCT07826520
- Record updated
- 17 September 2026
- Original description
Fibromyalgia is a chronic condition that commonly causes widespread pain, fatigue, and difficulty in daily activities. These symptoms may change from day to day, even when their average severity is similar.Read full original descriptionShow less
Relationship Between Daily Symptom Fluctuations and Functional Impact in Fibromyalgia
Fibromyalgia is a chronic condition that commonly causes widespread pain, fatigue, and difficulty in daily activities. These symptoms may change from day to day, even when their average severity is similar.
This study aims to examine whether daily changes in pain and fatigue are related to functional impact in adults with fibromyalgia. Participants will complete clinical questionnaires at the first visit and record their pain and fatigue levels for seven days. Sleep quality and perceived control over symptoms will also be recorded. No treatment or additional medical procedure will be given as part of the study.
Inclusion: Diagnosis of fibromyalgia according to the 2016 American College of Rheumatology criteria; Age between 18 and 65 years; Ability to understand and complete the daily symptom records; Ability and willingness to provide written informed consent.
Exclusion: Major change in fibromyalgia treatment within the previous three months; Active inflammatory rheumatic disease; Major neurological disease; Cognitive impairment or inability to provide informed consent; Pregnancy, postpartum period, or breastfeeding; Completion of less than 70% of the required daily symptom records; Major change in fibromyalgia treatment during the seven-day monitoring period.